![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1423-0232|72|1-2|33-38
ISSN: 0030-2414
Source: Oncology, Vol.72, Iss.1-2, 2007-11, pp. : 33-38
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A Pilot Phase II Study of Capecitabine in Advanced or Recurrent Gastric Cancer
Oncology, Vol. 64, Iss. 3, 2003-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phase II Study of Docetaxel and Capecitabine in Patients with Metastatic or Recurrent Gastric Cancer
Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. :